We are
bright.
hopeful.
human.
driven.
Omniscope.
It all started with a shift of mindset.
What if we can truly see and understand what our immune system is seeing? What if we can leverage our immune system to generate therapeutics, develop diagnostics, and monitor patients?
Omniscope was founded in 2020, by a multidisciplinary team of scientists and professionals who wanted to be of service to humanity at a critical moment for our species. We observed that “modern” medicine is using tools that tend to be too narrowly focused, time-consuming and misrepresenting. Too many groundbreaking scientific discoveries stay in the research field instead of helping patients.
What emerged is a technology based on the convergence between AI and immunology - to bring our humanistic vision of health equity to life. A mission-driven technology to put science in service of humanity.
The future of diagnostics & therapeutics.
See what your immune system is seeing.
Healthcare for everyone, everywhere.
Science is we all.
Holger leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis (one of Europe’s largest Genome Centres). He has co-authored over 80 publications, and his research has received over €7.5m funding from (inter)national agencies. Dr. Holger is a key opinion leader in the field of Genomics, a member of the Human Cell Atlas project and a partner of the LifeTime Initiative.
Vijay views technology as fundamental to humanity. He has been part of scaling companies such as Illumina and 10X Genomics. He has acquired and commercialised disruptive diagnostic technologies during his leadership at Siemens Healthineers and Meridian Biosciences. Vijay has been part of important IPOs in the biotechnology industry and finds his passion in improving health by the application of technology.
Lynnette brings to Omniscope her experience in the financial sector, where she served a diverse client base at Aberdeen Asset Management. These spanned government, private and public financial institutions including Sovereign Wealth Funds, Global Pensions, Central Banks, Insurers as well as Independent intermediates, global banks and online fund platforms.
Matthew wrote his first program on a 1982 BBC Micro Model B at the age of 4. After more than 20 years of working in all aspects of software, in both startups and multinationals, across a wide spectrum of industries ranging from warehouse robotics to hedge funds, Matthew is still as excited about tech today as he was back then.
Join us in our mission:
Healthcare for everyone, everywhere.
We know and believe in science. There’s much we don’t know, so we keep learning. From the immune system, the scientific community, nature, and beyond. To innovate, we look at things differently.
As scientists, collaboration feels natural. We listen to each other and nurture an ecosystem where everyone can contribute. The task is too great for one to solve, but together we can change the world.
We care about people and we want to help, starting with the vulnerable. Every day, we bring our humanity to work and let our compassion be a driver. We disrupt through inclusion.
We use science as a force for good. We see the human body as a tool, instead of reinventing the wheel. We simplify complex things for maximum efficiency, to have a big lasting impact.
838 Walker Road
Suite 21-2,
Dover, County of Kent
DE 19904, USA
Parc Científic de Barcelona
Cluster II - Floor 3
Avenida Doctor Marañon, 8
08028 Barcelona, Spain
230, 230 Works Business Centre Second Floor
Eucharistic Congress Road
Mosta, MST 9039, Malta
